OBJECTIVE: We examined the effect of restriction of foods with high fructose content in obese school children. METHODS: In a clinical study, we selected 54 obese children 6 to 11 years old with high fructose consumption (>70 g/day) in order indicate dietary fructose restriction (<20 g/day) for 6 weeks. Anthropometry, liver ultrasound as well as glucose, insulin, lipids, leptin, IGFBP1, and RBP4 serum levels were collected. RESULTS: The group of children had 80% adherence and reported decreased fructose consumption (110 ± 38.6 to 11.4 ± 12.0 g/day) and also a significant decrease in caloric (2,384 ± 568 to 1,757 ± 387 kcal/day) and carbohydrate consumption (302 ± 80.4 to 203 ± 56.0 g/day). The severity of steatosis improved significantly after fructose restriction (p < 0.000001). However, no changes in BMI, systolic blood pressure, or diastolic blood pressure were found. Only triglyceride levels decreased (1.44 ± 0.43 to 1.31 ± 0.38 mmol/l), High-densitiy lipoprotein cholesterol showed a marginal increase (1.45 ± 0.19 to 1.56 ± 0.44 mmol/l). Insulin resistance and RBP4 did not change. CONCLUSIONS: In school children, the restriction of high fructose foods with a decrease of caloric and carbohydrate intake at 6 weeks did not induce weight loss; however, triglyceride levels and hepatic steatosis decreased. Differences with other studies in regard to weight loss may be explained by adaptive changes on metabolic expenditure.
OBJECTIVE: We examined the effect of restriction of foods with high fructose content in obese school children. METHODS: In a clinical study, we selected 54 obesechildren 6 to 11 years old with high fructose consumption (>70 g/day) in order indicate dietary fructose restriction (<20 g/day) for 6 weeks. Anthropometry, liver ultrasound as well as glucose, insulin, lipids, leptin, IGFBP1, and RBP4 serum levels were collected. RESULTS: The group of children had 80% adherence and reported decreased fructose consumption (110 ± 38.6 to 11.4 ± 12.0 g/day) and also a significant decrease in caloric (2,384 ± 568 to 1,757 ± 387 kcal/day) and carbohydrate consumption (302 ± 80.4 to 203 ± 56.0 g/day). The severity of steatosis improved significantly after fructose restriction (p < 0.000001). However, no changes in BMI, systolic blood pressure, or diastolic blood pressure were found. Only triglyceride levels decreased (1.44 ± 0.43 to 1.31 ± 0.38 mmol/l), High-densitiy lipoprotein cholesterol showed a marginal increase (1.45 ± 0.19 to 1.56 ± 0.44 mmol/l). Insulin resistance and RBP4 did not change. CONCLUSIONS: In school children, the restriction of high fructose foods with a decrease of caloric and carbohydrate intake at 6 weeks did not induce weight loss; however, triglyceride levels and hepatic steatosis decreased. Differences with other studies in regard to weight loss may be explained by adaptive changes on metabolic expenditure.
Authors: Ran Jin; Ngoc-Anh Le; Shuling Liu; Monica Farkas Epperson; Thomas R Ziegler; Jean A Welsh; Dean P Jones; Craig J McClain; Miriam B Vos Journal: J Clin Endocrinol Metab Date: 2012-04-27 Impact factor: 5.958
Authors: Valentina Volynets; Jürgen Machann; Markus A Küper; Ina B Maier; Astrid Spruss; Alfred Königsrainer; Stephan C Bischoff; Ina Bergheim Journal: Eur J Nutr Date: 2012-04-28 Impact factor: 5.614
Authors: Jibran A Wali; Yen Chin Koay; Jason Chami; Courtney Wood; Leo Corcilius; Richard J Payne; Roman N Rodionov; Andreas L Birkenfeld; Dorit Samocha-Bonet; Stephen J Simpson; John F O'Sullivan Journal: Am J Physiol Endocrinol Metab Date: 2020-07-14 Impact factor: 4.310
Authors: Desiree M Sigala; Bettina Hieronimus; Valentina Medici; Vivien Lee; Marinelle V Nunez; Andrew A Bremer; Chad L Cox; Candice A Price; Yanet Benyam; Yasser Abdelhafez; John P McGahan; Nancy L Keim; Michael I Goran; Giovanni Pacini; Andrea Tura; Claude B Sirlin; Abhijit J Chaudhari; Peter J Havel; Kimber L Stanhope Journal: Nutrients Date: 2022-04-15 Impact factor: 6.706
Authors: Desiree M Sigala; Bettina Hieronimus; Valentina Medici; Vivien Lee; Marinelle V Nunez; Andrew A Bremer; Chad L Cox; Candice A Price; Yanet Benyam; Abhijit J Chaudhari; Yasser Abdelhafez; John P McGahan; Michael I Goran; Claude B Sirlin; Giovanni Pacini; Andrea Tura; Nancy L Keim; Peter J Havel; Kimber L Stanhope Journal: J Clin Endocrinol Metab Date: 2021-10-21 Impact factor: 6.134